78 results on '"Gharizadeh, B."'
Search Results
2. Identification of medically important fungi by the Pyrosequencing™ technology
- Author
-
Gharizadeh, B., Norberg, E., Löffler, J., Jalal, S., Tollemar, J., Einsele, H., Klingspor, L., and Nyrén, P.
- Published
- 2004
3. Pyrosequencing technology: a novel DNA sequencing technique for rapid and reliable typing of human papillomaviruses
- Author
-
Gharizadeh, B., Oggionni, M., Zheng, B., Pourmand, N., Akom, E., Wallin, K., and Nyren, P.
- Published
- 2004
4. MHC2TA A Single Nucleotide Polymorphism And Genetic Risk For Autoimmune Adrenal Insufficiency
- Author
-
Ghaderi, M, Gambelunghe, G, Tortoioli, C, Brozzetti, A, Jatta, K, Gharizadeh, B, DE BELLIS, A, PECIRI GIRALDI, F, Terzolo, M, Betterle, Corrado, and Falorni, A.
- Published
- 2006
5. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations
- Author
-
Toh, S. T., primary, Jin, Y., additional, Liu, L., additional, Wang, J., additional, Babrzadeh, F., additional, Gharizadeh, B., additional, Ronaghi, M., additional, Toh, H. C., additional, Chow, P. K.-H., additional, Chung, A. Y.-F., additional, Ooi, L. L.-P.-J., additional, and Lee, C. G.-L., additional
- Published
- 2012
- Full Text
- View/download PDF
6. Tu-P10:434 Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controls
- Author
-
Sheikine, Y., primary, Olsen, B., additional, Gharizadeh, B., additional, Jatta, K., additional, Tornvall, P., additional, and Ghaderi, M., additional
- Published
- 2006
- Full Text
- View/download PDF
7. Viral and microbial genotyping by a combination of multiplex competitive hybridization and specific extension followed by hybridization to generic tag arrays
- Author
-
Gharizadeh, B., primary
- Published
- 2003
- Full Text
- View/download PDF
8. PRYOSEQUENCING™; A NEW RAPID AND RELIABLE DNA‐SEQUENCING TECHNOLOGY FOR SPECIFIC IDENTIFICATION OF FUNGI, VIRUSES AND BACTERIA
- Author
-
Gharizadeh, B., primary, Löffler, J., additional, Norberg, E., additional, Tollemar, J., additional, Jalal, S., additional, Einsele, H., additional, Klingspor, L., additional, and Nyrén, P., additional
- Published
- 2002
- Full Text
- View/download PDF
9. Original article Identification of medically important fungi by the PyrosequencingTM technology Identifizierung medizinisch wichtiger Pilze mittels PyrosequencingTM-Technik.
- Author
-
Gharizadeh, B., Norberg, E., Löffler, J., Jalal, S., Tollemar, J., Einsele, H., Klingspor, L., and Nyrén, P.
- Subjects
- *
IDENTIFICATION of fungi , *RNA , *COMMUNICABLE disease treatment , *MYCOSES , *GEL electrophoresis , *OLIGONUCLEOTIDES , *PATHOGENIC microorganisms - Abstract
The PyrosequencingTM technology was used for identification of different clinically relevant fungi. The tests were performed on amplicons derived from the 18S rRNA gene using polymerase chain reaction (PCR) universal primers for amplification. Sequencing was performed up to 40 bases in a variable region with a designed general sequencing primer and the Pyrosequence data were analyzed by BLAST sequence search in the GenBank database. DNA from a total of 21 fungal specimens consisting of nine strains of clinically relevant fungi and 12 clinical specimens from patients suffering from proven invasive fungal infections were PCR-amplified and analyzed by gel electrophoresis, PCR-enzyme-linked immunosorbent assay (ELISA) and the Pyrosequencing technology. All data obtained by the Pyrosequencing technology were in agreement with the results obtained by PCR-ELISA using species/genus-specific oligonucleotides and were as well in accordance with the culture results. The results demonstrate that the Pyrosequencing method is a reproducible and reliable technique for identification of fungal pathogens. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
10. Mutation detection by pyrosequencing: sequencing of exons 5-8 of the p53 tumor suppressor gene
- Author
-
Garcia, C. A., Ahmadian, A., Gharizadeh, B., Lundeberg, J., Ronaghi, M., and Nyren, P.
- Published
- 2000
- Full Text
- View/download PDF
11. Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2
- Author
-
Skog, Alh, Wadhwa, M., Moustapha Hassan, Gharizadeh, B., Bird, C., Ragnhammar, P., Thorpe, R., and Mellstedt, H.
12. Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?
- Author
-
Strander B, Ryd W, Wallin KL, Wärleby B, Zheng B, Milsom I, Gharizadeh B, Pourmand N, and Andersson-Ellström A
- Abstract
BACKGROUND: Women once treated for high grade cervical dysplasia have a high long term risk for developing new dysplasia or cancer. OBJECTIVES: To investigate if human papilloma virus (HPV)-negativity after treatment of cervical dysplasia reduces the need for frequent long term follow up. DESIGN: Case/control study based on archival smears. METHODS: Women with cervical intraepithelial neoplasi (CIN)2-3, treated for dysplasia and with recurrence of CIN2+ more than 2 years after treatment were compared with controls without recurrence, matched for age and date of treatment. High risk-HPV-DNA were analysed with PCR from two archival smears per woman. Mean follow up time was 14.6 years. RESULTS: 24% (45/189) of cases and 11% (43/378) of controls were HPV-positive in any of two smears. Odds ratio (OR)=2.5 (1.6-3.8). CONCLUSION: HPV-status 6-12 months after treatment of high grade dysplasia is of limited value for the design of long term follow up. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
13. Development of a targeted amplicon sequencing method for genotyping Cyclospora cayetanensis from fresh produce and clinical samples with enhanced genomic resolution and sensitivity.
- Author
-
Leonard SR, Mammel MK, Gharizadeh B, Almeria S, Ma Z, Lipman DJ, Torrence ME, Wang C, and Musser SM
- Abstract
Outbreaks of cyclosporiasis, an enteric illness caused by the parasite Cyclospora cayetanensis , have been associated with consumption of various types of fresh produce. Although a method is in use for genotyping C. cayetanensis from clinical specimens, the very low abundance of C. cayetanensis in food and environmental samples presents a greater challenge. To complement epidemiological investigations, a molecular surveillance tool is needed for use in genetic linkage of food vehicles to cyclosporiasis illnesses, estimation of the scope of outbreaks or clusters of illness, and determination of geographical areas involved. We developed a targeted amplicon sequencing (TAS) assay that incorporates a further enrichment step to gain the requisite sensitivity for genotyping C. cayetanensis contaminating fresh produce samples. The TAS assay targets 52 loci, 49 of which are located in the nuclear genome, and encompasses 396 currently known SNP sites. The performance of the TAS assay was evaluated using lettuce, basil, cilantro, salad mix, and blackberries inoculated with C. cayetanensis oocysts. A minimum of 24 markers were haplotyped even at low contamination levels of 10 oocysts in 25 g leafy greens. The artificially contaminated fresh produce samples were included in a genetic distance analysis based on haplotype presence/absence with publicly available C. cayetanensis whole genome sequence assemblies. Oocysts from two different sources were used for inoculation, and samples receiving the same oocyst preparation clustered together, but separately from the other group, demonstrating the utility of the assay for genetically linking samples. Clinical fecal samples with low parasite loads were also successfully genotyped. This work represents a significant advance in the ability to genotype C. cayetanensis contaminating fresh produce along with greatly expanding the genomic diversity included for genetic clustering of clinical specimens., Competing Interests: CW, BG, and ZM were employed by Chapter Diagnostics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Leonard, Mammel, Gharizadeh, Almeria, Ma, Lipman, Torrence, Wang and Musser.)
- Published
- 2023
- Full Text
- View/download PDF
14. A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections.
- Author
-
Ma Z, Gharizadeh B, Cai X, Li M, Fellner MD, Basiletti JA, Correa RM, Colucci MC, Baldoni G, Vacchino M, Galarza P, Picconi MA, and Wang C
- Abstract
Background: Sexually transmitted infections (STIs) are prevalent throughout the world and impose a significant burden on individual health and public health systems. Missed diagnosis and late treatment of STIs can lead to serious complications such as infertility and cervical cancer. Although sexually transmitted co-infections are common, most commercial assays target one or a few STIs. The HPV-STI ChapterDx Next Generation Sequencing (NGS) assay detects and quantifies 29 HPVs and 14 other STIs in a single-tube and single-step PCR reaction and can be applied to tens to thousands of samples in a single sequencing run., Methods: A cohort of 274 samples, previously analyzed by conventional cytology/histology and Roche cobas HPV Test, were analyzed by ChapterDx HPV-STI NGS assay for detection of 43 HPV and STI. A set of 43 synthetic control DNA fragments for 43 HPV and STI were developed to evaluate the limit of detection, specificity, and sensitivity of ChapterDx HPV-STI NGS assay., Results: The assay was evaluated in this study, and the limit of detection was 100% at 50 copies for all targets, and 100%, 96%, 88% at 20 copies for 34, 8, and 1 target, respectively. The performance of this assay has been compared to Roche cobas HPV test, showing an overall agreement of 97.5% for hr-HPV, and 98.5% for both, HPV16 and HPV18. The assay also detected all HPV-infected CIN2/3 with 100% agreement with Roche cobas HPV results. Moreover, several co-infections with non-HPV STIs, such as C. trachomatis, T. vaginalis, M. genitalium, and HSV2 were identified., Conclusions: The ChapterDx HPV-STI NGS assay is a user-friendly, easy to automate and cost-efficient assay, which provides accurate and comprehensive results for a wide spectrum of HPVs and STIs., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
15. Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management.
- Author
-
Gharizadeh B, Yue J, Yu M, Liu Y, Zhou M, Lu D, and Zhang J
- Subjects
- Animals, Humans, Life Cycle Stages, Pandemics prevention & control, SARS-CoV-2 immunology, Serologic Tests methods, COVID-19 diagnosis, COVID-19 immunology, Immunoassay methods, Pathology, Molecular methods
- Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.
- Published
- 2021
- Full Text
- View/download PDF
16. Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.
- Author
-
Högfeldt T, Jaing C, Loughlin KM, Thissen J, Gardner S, Bahnassy AA, Gharizadeh B, Lundahl J, Österborg A, Porwit A, Zekri AN, Khaled HM, Mellstedt H, and Moshfegh A
- Abstract
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin's lymphoma (NHL) in adults, accounts for approximately 30-40% of newly diagnosed lymphomas worldwide. Environmental factors, such as viruses and bacteria, may contribute to cancer development through chronic inflammation and the integration of oncogenes, and have previously been indicated in cervical cancer, hepatocellular carcinoma, gastric cancer and lymphoproliferative disorders. In the present study, the presence of microbial agents was analyzed in the lymphoma tissue of patients with activated B-cell like (ABC) DLBCL. The present study compared two groups of patients from geographically varied regions that possess a difference in the prevalence of viral and other microbial agents. The patient populations were from Sweden (a low endemic infectious disease region) and Egypt (a high endemic infectious disease region). A differential expression of several viruses in lymphoma tissues was noted when comparing Swedish and Egyptian patients. JC polyomavirus (JCV) was detected in Swedish and Egyptian patients and, uniquely, the complete hepatitis B virus (HBV) genome was detected only in Egyptian lymphoma patients. None of these viruses were detected in control lymph tissues from Sweden or Egypt. In total, 38% of the Egyptian patients were found to have HBV surface antigens (HBsAgs) in their serum; however, HBsAgs were not found in any of the Swedish patients. The percentage of serum HBsAgs in Egyptian patients with ABC DLBCL was significantly increased compared with the general Egyptian population (P<0.05). The present study may support a notion that viral agents, including JCV and HBV, may be involved in the tumorigenesis of DLBCL in regions of high infectious disease.
- Published
- 2016
- Full Text
- View/download PDF
17. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.
- Author
-
Chen X, Wallin KL, Duan M, Gharizadeh B, Zheng B, and Qu P
- Subjects
- Adult, Aged, Biopsy, China epidemiology, Coinfection epidemiology, Coinfection virology, Colposcopy, Early Detection of Cancer, Female, Human papillomavirus 16, Humans, Middle Aged, Molecular Epidemiology, Papillomaviridae isolation & purification, Polymerase Chain Reaction, Prevalence, Sequence Analysis, DNA, Young Adult, Cervix Uteri virology, Genotype, Papillomaviridae classification, Papillomaviridae genetics, Papillomavirus Infections epidemiology, Papillomavirus Infections virology
- Abstract
To investigate the prevalence and genotype distribution of human papillomavirus (HPV) infection among women in urban Tianjin, China. A cervical cancer screening program for 2,000 women aged 21-65 years old was performed in urban Tianjin from April to October in 2013. The program included ThinPrep cytologic tests (TCT), HPV DNA detection and genotyping using nested polymerase chain reaction (PCR) combined with Pyrosequencing technology. Colposcopy examination and biopsy were needed if TCT reported greater or equal atypical cells of undetermined significance (ASCUS). One thousand nine hundred seventy-eight women were enrolled in the final study, 14.71% (291/1,978) of women were tested HPV positive. Of HPV-positive specimens, 248 (85.22%) and 43 (14.78%) were infected with high- and low-risk HPV genotypes, respectively. Twenty-eight types of HPV were detected in all, the most frequently detected types were HPV16, 58, 18, and 66 orderly. The single infection rate was 92.28% among HPV-positive samples while the multiple infection rate was 7.72%. Among multiple infection models, HPV16 was the most common type co-infection with other types. This study is, to our knowledge, the first population-based survey to provide data on HPV infection and genotype distribution among women in urban Tianjin, China. There was a high prevalence of HPV infection in this area, and HPV16, 58, 18, 66 were the most frequently detected genotypes. Our study provide important information regarding the necessity of early cervical cancer screenings and prophylactic HPV vaccinations, and the knowledge of HPV distribution can also inform us about the HPV ecological change after the vaccination., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
18. Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissues.
- Author
-
Gottlieb B, Alvarado C, Wang C, Gharizadeh B, Babrzadeh F, Richards B, Batist G, Basik M, Beitel LK, and Trifiro M
- Subjects
- Aged, Aged, 80 and over, Breast Neoplasms pathology, Case-Control Studies, Female, Humans, Middle Aged, Neoplasm Grading, Neoplasm Staging, Breast Neoplasms genetics, Genetic Variation, Receptors, Androgen genetics, Trinucleotide Repeats
- Abstract
To examine the significance of intratumor genetic heterogeneity (ITGH) of the androgen receptor (AR) gene in breast cancer, patient-matched samples of laser capture microdissected breast tumor cells, adjacent normal breast epithelia cells, and peripheral blood leukocytes were sequenced using a novel next generation sequencing protocol. This protocol measured the frequency of distribution of a variable AR CAG repeat length, a functional polymorphism associated with breast cancer risk. All samples exhibited some degree of ITGH with up to 30 CAG repeat length variants identified. Each type of tissue exhibited a different distribution profile of CAG repeat lengths with substantial differences in the frequencies of zero and 18-25 CAG AR variants. Tissue differences in the frequency of ARs with each of these CAG repeat lengths were significant as measured by paired, twin t-tests. These results suggest that preferential selection of 18-25 CAG repeat length variants in breast tumors may be associated with breast cancer, and support the observation that shorter CAG repeats may protect against breast cancer. They also suggest that merely identifying variant genes will be insufficient to determine the critical mutational events of oncogenesis, which will require measuring the frequency of distribution of mutations within cancerous and matching normal tissues., (© 2013 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
19. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
- Author
-
Toh ST, Jin Y, Liu L, Wang J, Babrzadeh F, Gharizadeh B, Ronaghi M, Toh HC, Chow PK, Chung AY, Ooi LL, and Lee CG
- Subjects
- Amino Acid Substitution, Base Sequence, Carcinoma, Hepatocellular complications, Carcinoma, Hepatocellular genetics, Cell Line, Chromosomes, Human, Pair 10 virology, DNA, Viral genetics, Genetic Variation, Hepatitis B, Chronic complications, High-Throughput Nucleotide Sequencing, Humans, Liver Neoplasms genetics, Promoter Regions, Genetic, Sequence Analysis, DNA, Telomerase biosynthesis, Trans-Activators genetics, Viral Regulatory and Accessory Proteins, Virus Integration genetics, Carcinoma, Hepatocellular virology, Hepatitis B virus genetics, Liver Neoplasms virology, Telomerase genetics
- Abstract
Chronic hepatitis B virus (HBV) infection is epidemiologically associated with hepatocellular carcinoma (HCC), but its role in HCC remains poorly understood due to technological limitations. In this study, we systematically characterize HBV in HCC patients. HBV sequences were enriched from 48 HCC patients using an oligo-bead-based strategy, pooled together and sequenced using the FLX-Genome-Sequencer. In the tumors, preferential integration of HBV into promoters of genes (P < 0.001) and significant enrichment of integration into chromosome 10 (P < 0.01) were observed. Integration into chromosome 10 was significantly associated with poorly differentiated tumors (P < 0.05). Notably, in the tumors, recurrent integration into the promoter of the human telomerase reverse transcriptase (TERT) gene was found to correlate with increased TERT expression. The preferred region within the HBV genome involved in integration and viral structural alteration is at the 3'-end of hepatitis B virus X protein (HBx), where viral replication/transcription initiates. Upon integration, the 3'-end of the HBx is often deleted. HBx-human chimeric transcripts, the most common type of chimeric transcripts, can be expressed as chimeric proteins. Sequence variation resulting in non-conservative amino acid substitutions are commonly observed in HBV genome. This study highlights HBV as highly mutable in HCC patients with preferential regions within the host and virus genome for HBV integration/structural alterations.
- Published
- 2013
- Full Text
- View/download PDF
20. Whole-genome sequencing of the efficient industrial fuel-ethanol fermentative Saccharomyces cerevisiae strain CAT-1.
- Author
-
Babrzadeh F, Jalili R, Wang C, Shokralla S, Pierce S, Robinson-Mosher A, Nyren P, Shafer RW, Basso LC, de Amorim HV, de Oliveira AJ, Davis RW, Ronaghi M, Gharizadeh B, and Stambuk BU
- Subjects
- Biotechnology, Diploidy, Fermentation genetics, Gene Dosage, Phylogeny, Polymorphism, Single Nucleotide, Saccharomyces cerevisiae classification, Sequence Analysis, DNA, Species Specificity, Biofuels, Ethanol metabolism, Genome, Fungal, Saccharomyces cerevisiae genetics, Saccharomyces cerevisiae metabolism
- Abstract
The Saccharomyces cerevisiae strains widely used for industrial fuel-ethanol production have been developed by selection, but their underlying beneficial genetic polymorphisms remain unknown. Here, we report the draft whole-genome sequence of the S. cerevisiae strain CAT-1, which is a dominant fuel-ethanol fermentative strain from the sugarcane industry in Brazil. Our results indicate that strain CAT-1 is a highly heterozygous diploid yeast strain, and the ~12-Mb genome of CAT-1, when compared with the reference S228c genome, contains ~36,000 homozygous and ~30,000 heterozygous single nucleotide polymorphisms, exhibiting an uneven distribution among chromosomes due to large genomic regions of loss of heterozygosity (LOH). In total, 58 % of the 6,652 predicted protein-coding genes of the CAT-1 genome constitute different alleles when compared with the genes present in the reference S288c genome. The CAT-1 genome contains a reduced number of transposable elements, as well as several gene deletions and duplications, especially at telomeric regions, some correlated with several of the physiological characteristics of this industrial fuel-ethanol strain. Phylogenetic analyses revealed that some genes were likely associated with traits important for bioethanol production. Identifying and characterizing the allelic variations controlling traits relevant to industrial fermentation should provide the basis for a forward genetics approach for developing better fermenting yeast strains.
- Published
- 2012
- Full Text
- View/download PDF
21. The shaping of modern human immune systems by multiregional admixture with archaic humans.
- Author
-
Abi-Rached L, Jobin MJ, Kulkarni S, McWhinnie A, Dalva K, Gragert L, Babrzadeh F, Gharizadeh B, Luo M, Plummer FA, Kimani J, Carrington M, Middleton D, Rajalingam R, Beksac M, Marsh SG, Maiers M, Guethlein LA, Tavoularis S, Little AM, Green RE, Norman PJ, and Parham P
- Subjects
- Adaptation, Biological, Alleles, Animals, Asian People genetics, Black People genetics, Evolution, Molecular, Genetic Variation, HLA-A Antigens immunology, HLA-A Antigens metabolism, HLA-B Antigens immunology, HLA-B Antigens metabolism, HLA-C Antigens immunology, Haplotypes, Humans, Killer Cells, Natural immunology, Ligands, Linkage Disequilibrium, Molecular Sequence Data, Native Hawaiian or Other Pacific Islander genetics, Receptors, KIR immunology, Receptors, KIR metabolism, Selection, Genetic, White People genetics, Genes, MHC Class I, HLA-A Antigens genetics, HLA-B Antigens genetics, HLA-C Antigens genetics, Hominidae genetics, Hominidae immunology, Hybridization, Genetic, Racial Groups genetics
- Abstract
Whole genome comparisons identified introgression from archaic to modern humans. Our analysis of highly polymorphic human leukocyte antigen (HLA) class I, vital immune system components subject to strong balancing selection, shows how modern humans acquired the HLA-B*73 allele in west Asia through admixture with archaic humans called Denisovans, a likely sister group to the Neandertals. Virtual genotyping of Denisovan and Neandertal genomes identified archaic HLA haplotypes carrying functionally distinctive alleles that have introgressed into modern Eurasian and Oceanian populations. These alleles, of which several encode unique or strong ligands for natural killer cell receptors, now represent more than half the HLA alleles of modern Eurasians and also appear to have been later introduced into Africans. Thus, adaptive introgression of archaic alleles has significantly shaped modern human immune systems.
- Published
- 2011
- Full Text
- View/download PDF
22. Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.
- Author
-
Gleimer M, Wahl AR, Hickman HD, Abi-Rached L, Norman PJ, Guethlein LA, Hammond JA, Draghi M, Adams EJ, Juo S, Jalili R, Gharizadeh B, Ronaghi M, Garcia KC, Hildebrand WH, and Parham P
- Subjects
- Animals, Binding Sites genetics, Binding Sites immunology, Cloning, Molecular, Conserved Sequence genetics, HLA-A Antigens chemistry, HLA-A Antigens genetics, HLA-A2 Antigen, Histocompatibility Antigens Class I chemistry, Histocompatibility Antigens Class I genetics, Humans, Molecular Sequence Data, Pan troglodytes, Peptides chemistry, Peptides genetics, Protein Binding genetics, Protein Binding immunology, Receptors, Antigen, T-Cell metabolism, Conserved Sequence immunology, Genes, Overlapping immunology, HLA-A Antigens metabolism, Histocompatibility Antigens Class I metabolism, Peptides metabolism, Polymorphism, Genetic
- Abstract
Patr-AL is an expressed, non-polymorphic MHC class I gene carried by ∼50% of chimpanzee MHC haplotypes. Comparing Patr-AL(+) and Patr-AL(-) haplotypes showed Patr-AL defines a unique 125-kb genomic block flanked by blocks containing classical Patr-A and pseudogene Patr-H. Orthologous to Patr-AL are polymorphic orangutan Popy-A and the 5' part of human pseudogene HLA-Y, carried by ∼10% of HLA haplotypes. Thus, the AL gene alternatively evolved in these closely related species to become classical, nonclassical, and nonfunctional. Although differing by 30 aa substitutions in the peptide-binding α(1) and α(2) domains, Patr-AL and HLA-A*0201 bind overlapping repertoires of peptides; the overlap being comparable with that between the A*0201 and A*0207 subtypes differing by one substitution. Patr-AL thus has the A02 supertypic peptide-binding specificity. Patr-AL and HLA-A*0201 have similar three-dimensional structures, binding peptides in similar conformation. Although comparable in size and shape, the B and F specificity pockets of Patr-AL and HLA-A*0201 differ in both their constituent residues and contacts with peptide anchors. Uniquely shared by Patr-AL, HLA-A*0201, and other members of the A02 supertype are the absence of serine at position 9 in the B pocket and the presence of tyrosine at position 116 in the F pocket. Distinguishing Patr-AL from HLA-A*02 is an unusually electropositive upper face on the α(2) helix. Stimulating PBMCs from Patr-AL(-) chimpanzees with B cells expressing Patr-AL produced potent alloreactive CD8 T cells with specificity for Patr-AL and no cross-reactivity toward other MHC class I molecules, including HLA-A*02. In contrast, PBMCs from Patr-AL(+) chimpanzees are tolerant of Patr-AL.
- Published
- 2011
- Full Text
- View/download PDF
23. High-fidelity gene synthesis by retrieval of sequence-verified DNA identified using high-throughput pyrosequencing.
- Author
-
Matzas M, Stähler PF, Kefer N, Siebelt N, Boisguérin V, Leonard JT, Keller A, Stähler CF, Häberle P, Gharizadeh B, Babrzadeh F, and Church GM
- Subjects
- DNA chemistry, Humans, Oligonucleotides chemical synthesis, Oligonucleotides chemistry, Robotics, DNA chemical synthesis, Genes, Synthetic, Oligonucleotide Array Sequence Analysis methods, Polymerase Chain Reaction methods
- Abstract
The construction of synthetic biological systems involving millions of nucleotides is limited by the lack of high-quality synthetic DNA. Consequently, the field requires advances in the accuracy and scale of chemical DNA synthesis and in the processing of longer DNA assembled from short fragments. Here we describe a highly parallel and miniaturized method, called megacloning, for obtaining high-quality DNA by using next-generation sequencing (NGS) technology as a preparative tool. We demonstrate our method by processing both chemically synthesized and microarray-derived DNA oligonucleotides with a robotic system for imaging and picking beads directly off of a high-throughput pyrosequencing platform. The method can reduce error rates by a factor of 500 compared to the starting oligonucleotide pool generated by microarray. We use DNA obtained by megacloning to assemble synthetic genes. In principle, millions of DNA fragments can be sequenced, characterized and sorted in a single megacloner run, enabling constructive biology up to the megabase scale.
- Published
- 2010
- Full Text
- View/download PDF
24. Pyrosequencing enhancement for better detection limit and sequencing homopolymers.
- Author
-
Gong M, Foo SH, Lin L, Liu ET, Gharizadeh B, and Goel S
- Subjects
- DNA analysis, DNA genetics, Polymers analysis, DNA chemistry, Polymers chemistry, Sequence Analysis, DNA methods
- Abstract
Pyrosequencing is a DNA sequencing technique based on sequencing-by-synthesis enabling rapid and real-time sequence determination. Although ample genomic research has been undertaken using pyrosequencing, the requirement of relatively high amount of DNA template and the difficulty in sequencing the homopolymeric regions limit its key advantages in the applications directing towards clinical research. In this study, we demonstrate that pyrosequencing on homopolymeric regions with 10 identical nucleotides can be successfully performed with optimal amount of DNA (0.3125-5 pmol) immobilized on conventional non-porous Sepharose beads. We also validate that by using porous silica beads, the sequencing signal increased 3.5-folds as compared to that produced from same amount of DNA immobilized on solid Sepharose beads. Our results strongly indicate that with optimized quantity of DNA and suitable solid support, the performance of pyrosequencing on homopolymeric regions and its detection limit has been significantly improved., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
25. Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation.
- Author
-
Varghese V, Wang E, Babrzadeh F, Bachmann MH, Shahriar R, Liu T, Mappala SJ, Gharizadeh B, Fessel WJ, Katzenstein D, Kassaye S, and Shafer RW
- Subjects
- Base Sequence, DNA Primers, DNA, Viral genetics, HIV-1 genetics, Mutagenesis, Site-Directed, Plasmids, Polymerase Chain Reaction, Drug Resistance, Viral genetics, HIV-1 drug effects, Mutation, Templates, Genetic
- Abstract
Background: The HIV-1 nucleoside RT inhibitor (NRTI)-resistance mutation, K65R confers intermediate to high-level resistance to the NRTIs abacavir, didanosine, emtricitabine, lamivudine, and tenofovir; and low-level resistance to stavudine. Several lines of evidence suggest that K65R is more common in HIV-1 subtype C than subtype B viruses., Methods and Findings: We performed ultra-deep pyrosequencing (UDPS) and clonal dideoxynucleotide sequencing of plasma virus samples to assess the prevalence of minority K65R variants in subtype B and C viruses from untreated individuals. Although UDPS of plasma samples from 18 subtype C and 27 subtype B viruses showed that a higher proportion of subtype C viruses contain K65R (1.04% vs. 0.25%; p<0.001), limiting dilution clonal sequencing failed to corroborate its presence in two of the samples in which K65R was present in >1.5% of UDPS reads. We therefore performed UDPS on clones and site-directed mutants containing subtype B- and C-specific patterns of silent mutations in the conserved KKK motif encompassing RT codons 64 to 66 and found that subtype-specific nucleotide differences were responsible for increased PCR-induced K65R mutation in subtype C viruses., Conclusions: This study shows that the RT KKK nucleotide template in subtype C viruses can lead to the spurious detection of K65R by highly sensitive PCR-dependent sequencing techniques. However, the study is also consistent with the subtype C nucleotide template being inherently responsible for increased polymerization-induced K65R mutations in vivo.
- Published
- 2010
- Full Text
- View/download PDF
26. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems.
- Author
-
Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, Doukas T, Paranjape S, Polacek C, dos Santos FB, Jalili R, Babrzadeh F, Gharizadeh B, Grimm D, Kay M, Koike S, Sarnow P, Ronaghi M, Ding SW, Harris E, Chow M, Diamond MS, Kirkegaard K, Glenn JS, and Fire AZ
- Subjects
- Animals, Invertebrates genetics, MicroRNAs, RNA Viruses, RNA, Small Interfering, Invertebrates virology, RNA Virus Infections genetics, RNA, Viral genetics, Vertebrates genetics, Vertebrates virology
- Abstract
We have used multiplexed high-throughput sequencing to characterize changes in small RNA populations that occur during viral infection in animal cells. Small RNA-based mechanisms such as RNA interference (RNAi) have been shown in plant and invertebrate systems to play a key role in host responses to viral infection. Although homologs of the key RNAi effector pathways are present in mammalian cells, and can launch an RNAi-mediated degradation of experimentally targeted mRNAs, any role for such responses in mammalian host-virus interactions remains to be characterized. Six different viruses were examined in 41 experimentally susceptible and resistant host systems. We identified virus-derived small RNAs (vsRNAs) from all six viruses, with total abundance varying from "vanishingly rare" (less than 0.1% of cellular small RNA) to highly abundant (comparable to abundant micro-RNAs "miRNAs"). In addition to the appearance of vsRNAs during infection, we saw a number of specific changes in host miRNA profiles. For several infection models investigated in more detail, the RNAi and Interferon pathways modulated the abundance of vsRNAs. We also found evidence for populations of vsRNAs that exist as duplexed siRNAs with zero to three nucleotide 3' overhangs. Using populations of cells carrying a Hepatitis C replicon, we observed strand-selective loading of siRNAs onto Argonaute complexes. These experiments define vsRNAs as one possible component of the interplay between animal viruses and their hosts.
- Published
- 2010
- Full Text
- View/download PDF
27. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets.
- Author
-
Wang C, Sanders CM, Yang Q, Schroeder HW Jr, Wang E, Babrzadeh F, Gharizadeh B, Myers RM, Hudson JR Jr, Davis RW, and Han J
- Subjects
- Amino Acid Sequence, Cell Differentiation, Cell Lineage, Humans, Receptors, Antigen, T-Cell chemistry, T-Lymphocyte Subsets chemistry, T-Lymphocyte Subsets cytology, Receptors, Antigen, T-Cell immunology, T-Lymphocyte Subsets immunology
- Abstract
Developing T cells face a series of cell fate choices in the thymus and in the periphery. The role of the individual T cell receptor (TCR) in determining decisions of cell fate remains unresolved. The stochastic/selection model postulates that the initial fate of the cell is independent of TCR specificity, with survival dependent on additional TCR/coreceptor "rescue" signals. The "instructive" model holds that cell fate is initiated by the interaction of the TCR with a cognate peptide-MHC complex. T cells are then segregated on the basis of TCR specificity with the aid of critical coreceptors and signal modulators [Chan S, Correia-Neves M, Benoist C, Mathis (1998) Immunol Rev 165: 195-207]. The former would predict a random representation of individual TCR across divergent T cell lineages whereas the latter would predict minimal overlap between divergent T cell subsets. To address this issue, we have used high-throughput sequencing to evaluate the TCR distribution among key T cell developmental and effector subsets from a single donor. We found numerous examples of individual subsets sharing identical TCR sequence, supporting a model of a stochastic process of cell fate determination coupled with dynamic patterns of clonal expansion of T cells bearing the same TCR sequence among both CD4(+) and CD8+ populations.
- Published
- 2010
- Full Text
- View/download PDF
28. Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors.
- Author
-
Varghese V, Shahriar R, Rhee SY, Liu T, Simen BB, Egholm M, Hanczaruk B, Blake LA, Gharizadeh B, Babrzadeh F, Bachmann MH, Fessel WJ, and Shafer RW
- Subjects
- Anti-HIV Agents therapeutic use, Drug Therapy, Combination, Genetic Variation, Genotype, HIV Infections blood, HIV Infections virology, HIV Reverse Transcriptase, Humans, Mutation, Nitriles, Pyridazines pharmacology, Pyridazines therapeutic use, Pyrimidines, Anti-HIV Agents pharmacology, Drug Resistance, Multiple, Viral, HIV Infections drug therapy, HIV-1 drug effects, HIV-1 genetics
- Abstract
Objectives: K103N, the most common nonnucleoside reverse transcriptase inhibitor (NNRTI)-resistant mutation in patients with transmitted resistance and in patients receiving a failing NNRTI-containing regimen, is fully susceptible to the new NNRTI, etravirine. Therefore, we sought to determine how often NNRTI-resistant mutations other than K103N occur as minority variants in plasma samples for which standard genotypic resistance testing detects K103N alone., Methods: We performed ultradeep pyrosequencing (UDPS; 454 Life Sciences a Roche Company, Branford, CT) of plasma virus samples from 13 treatment-naive and 20 NNRTI-experienced patients in whom standard genotypic resistance testing revealed K103N but no other major NNRTI-resistance mutations., Results: Samples from 0 of 13 treatment-naive patients vs. 7 of 20 patients failing an NNRTI-containing regimen had minority variants with major etravirine-associated NNRTI-resistant mutations (P = 0.03, Fisher exact test): Y181C (7.0%), Y181C (3.6%) + G190A (3.2%), L100I (14%), L100I (32%) + 190A (5.4%), K101E (3.8%) + G190A (4.9%), K101E (4.0%) + G190S (4.8%), and G190S (3.1%)., Conclusions: In treatment-naive patients, UDPS did not detect additional major NNRTI-resistant mutations suggesting that etravirine may be effective in patients with transmitted K103N. In NNRTI-experienced patients, UDPS often detected additional major NNRTI-resistant mutations suggesting that etravirine may not be fully active in patients with acquired K103N.
- Published
- 2009
- Full Text
- View/download PDF
29. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.
- Author
-
Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, Holmes SP, Babrzadeh F, Gharizadeh B, Hanczaruk B, Simen BB, Egholm M, and Shafer RW
- Subjects
- Adenine analogs & derivatives, Adenine therapeutic use, Antiviral Agents therapeutic use, Base Sequence, DNA Primers, DNA, Viral genetics, DNA, Viral isolation & purification, Drug Resistance, Viral, Genetic Variation, Genotype, HIV Infections complications, HIV Infections drug therapy, Hepatitis B complications, Hepatitis B drug therapy, Hepatitis B virus drug effects, Hepatitis B virus isolation & purification, Humans, Lamivudine therapeutic use, Mutation, Organophosphonates therapeutic use, Polymerase Chain Reaction, RNA-Directed DNA Polymerase, Hepatitis B virology, Hepatitis B virus genetics, Reverse Transcriptase Inhibitors therapeutic use
- Abstract
The dynamics of emerging nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI) resistance in hepatitis B virus (HBV) are not well understood because standard dideoxynucleotide direct polymerase chain reaction (PCR) sequencing assays detect drug-resistance mutations only after they have become dominant. To obtain insight into NRTI resistance, we used a new sequencing technology to characterize the spectrum of low-prevalence NRTI-resistance mutations in HBV obtained from 20 plasma samples from 11 NRTI-treated patients and 17 plasma samples from 17 NRTI-naive patients, by using standard direct PCR sequencing and ultra-deep pyrosequencing (UDPS). UDPS detected drug-resistance mutations that were not detected by PCR in 10 samples from 5 NRTI-treated patients, including the lamivudine-resistance mutation V173L (in 5 samples), the entecavir-resistance mutations T184S (in 2 samples) and S202G (in 1 sample), the adefovir-resistance mutation N236T (in 1 sample), and the lamivudine and adefovir-resistance mutations V173L, L180M, A181T, and M204V (in 1 sample). G-to-A hypermutation mediated by the apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like family of cytidine deaminases was estimated to be present in 0.6% of reverse-transcriptase genes. Genotype A coinfection was detected by UDPS in each of 3 patients in whom genotype G virus was detected by direct PCR sequencing. UDPS detected low-prevalence HBV variants with NRTI-resistance mutations, G-to-A hypermutation, and low-level dual genotype infection with a sensitivity not previously possible.
- Published
- 2009
- Full Text
- View/download PDF
30. Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.
- Author
-
Mitsuya Y, Varghese V, Wang C, Liu TF, Holmes SP, Jayakumar P, Gharizadeh B, Ronaghi M, Klein D, Fessel WJ, and Shafer RW
- Subjects
- Anti-Retroviral Agents therapeutic use, CD4 Lymphocyte Count, Codon, HIV Infections drug therapy, HIV-1 classification, HIV-1 isolation & purification, Humans, Viral Load, Drug Resistance, Viral, HIV Infections virology, HIV Reverse Transcriptase genetics, HIV-1 genetics, Mutation, Missense, Sequence Analysis, DNA methods, Suppression, Genetic
- Abstract
T215 revertant mutations such as T215C/D/E/S that evolve from the nucleoside reverse transcriptase (RT) inhibitor mutations T215Y/F have been found in about 3% of human immunodeficiency virus type 1 (HIV-1) isolates from newly diagnosed HIV-1-infected persons. We used a newly developed sequencing method-ultradeep pyrosequencing (UDPS; 454 Life Sciences)--to determine the frequency with which T215Y/F or other RT inhibitor resistance mutations could be detected as minority variants in samples from untreated persons that contain T215 revertants ("revertant" samples) compared with samples from untreated persons that lack such revertants ("control" samples). Among the 22 revertant and 29 control samples, UDPS detected a mean of 3.8 and 4.8 additional RT amino acid mutations, respectively. In 6 of 22 (27%) revertant samples and in 4 of 29 control samples (14%; P = 0.4), UDPS detected one or more RT inhibitor resistance mutations. T215Y or T215F was not detected in any of the revertant or control samples; however, 4 of 22 revertant samples had one or more T215 revertants that were detected by UDPS but not by direct PCR sequencing. The failure to detect viruses with T215Y/F in the 22 revertant samples in this study may result from the overwhelming replacement of transmitted T215Y variants by the more fit T215 revertants or from the primary transmission of a T215 revertant in a subset of persons with T215 revertants.
- Published
- 2008
- Full Text
- View/download PDF
31. High throughput automated allele frequency estimation by pyrosequencing.
- Author
-
Doostzadeh J, Shokralla S, Absalan F, Jalili R, Mohandessi S, Langston JW, Davis RW, Ronaghi M, and Gharizadeh B
- Subjects
- Alleles, Automation, Biotin chemistry, Case-Control Studies, DNA Mutational Analysis methods, DNA Primers chemistry, Gene Frequency, Genetic Techniques, Genotype, Humans, Molecular Biology methods, Parkinson Disease genetics, Reproducibility of Results, Diphosphates chemistry, Sequence Analysis, DNA methods
- Abstract
Pyrosequencing is a DNA sequencing method based on the principle of sequencing-by-synthesis and pyrophosphate detection through a series of enzymatic reactions. This bioluminometric, real-time DNA sequencing technique offers unique applications that are cost-effective and user-friendly. In this study, we have combined a number of methods to develop an accurate, robust and cost efficient method to determine allele frequencies in large populations for association studies. The assay offers the advantage of minimal systemic sampling errors, uses a general biotin amplification approach, and replaces dTTP for dATP-apha-thio to avoid non-uniform higher peaks in order to increase accuracy. We demonstrate that this newly developed assay is a robust, cost-effective, accurate and reproducible approach for large-scale genotyping of DNA pools. We also discuss potential improvements of the software for more accurate allele frequency analysis.
- Published
- 2008
- Full Text
- View/download PDF
32. Viral population estimation using pyrosequencing.
- Author
-
Eriksson N, Pachter L, Mitsuya Y, Rhee SY, Wang C, Gharizadeh B, Ronaghi M, Shafer RW, and Beerenwinkel N
- Subjects
- Base Sequence, Genetic Variation genetics, HIV classification, Molecular Sequence Data, Algorithms, Chromosome Mapping methods, DNA, Viral genetics, HIV genetics, HIV isolation & purification, Sequence Alignment methods, Sequence Analysis, DNA methods
- Abstract
The diversity of virus populations within single infected hosts presents a major difficulty for the natural immune response as well as for vaccine design and antiviral drug therapy. Recently developed pyrophosphate-based sequencing technologies (pyrosequencing) can be used for quantifying this diversity by ultra-deep sequencing of virus samples. We present computational methods for the analysis of such sequence data and apply these techniques to pyrosequencing data obtained from HIV populations within patients harboring drug-resistant virus strains. Our main result is the estimation of the population structure of the sample from the pyrosequencing reads. This inference is based on a statistical approach to error correction, followed by a combinatorial algorithm for constructing a minimal set of haplotypes that explain the data. Using this set of explaining haplotypes, we apply a statistical model to infer the frequencies of the haplotypes in the population via an expectation-maximization (EM) algorithm. We demonstrate that pyrosequencing reads allow for effective population reconstruction by extensive simulations and by comparison to 165 sequences obtained directly from clonal sequencing of four independent, diverse HIV populations. Thus, pyrosequencing can be used for cost-effective estimation of the structure of virus populations, promising new insights into viral evolutionary dynamics and disease control strategies.
- Published
- 2008
- Full Text
- View/download PDF
33. Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients.
- Author
-
Laytragoon-Lewin N, Nilsson PJ, Castro J, Gharizadeh B, Nyren P, Glimelius B, Elmberger G, Turesson I, and Svensson C
- Subjects
- Aged, Anus Neoplasms mortality, Carcinoma, Squamous Cell mortality, Cell Cycle, Chromosome Aberrations, Female, Humans, In Situ Hybridization, Kaplan-Meier Estimate, Male, Papillomavirus Infections complications, Polymerase Chain Reaction, Prevalence, Anus Neoplasms genetics, Anus Neoplasms virology, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell virology, DNA, Neoplasm genetics, Papillomaviridae isolation & purification, Tumor Virus Infections
- Abstract
Unlabelled: Human papillomavirus (HPV) infections of the genital tract are sexually transmitted and prevalent worldwide. In this study, the role of HPV in 72 patients with anal squamous cell carcinoma was investigated., Patients and Methods: Polymerase chain reaction (PCR) in combination with in situ hybridization was used to identify HPV-DNA in the patients' biopsies. The HPV typing was conducted by pyrosequencing. Cell cycle and DNA content were analysed by cytometry., Results: Ninety percent of the carcinoma biopsies carried high-risk oncogenic HPV in their malignant cells. Eighty-one percent of these demonstrated a single infection with HPV16, 18 or 33 and 19% were double infected with HPV16 and HPV18. Accumulations of viral genes were seen at the necrotic area of the tumours. The HPV genome in the tumour cell influenced significantly the host cell cycle progression, but not DNA aberrations. Within these patients, HPVstatus in the malignant cells was not found to be associated with patient survival time., Conclusion: High-risk oncogenic HPV may play an important role in the initiation of host cell proliferation in anal squamous cell carcinoma. However, infection with HPV may not have any direct influence itself on the clinical outcome of these patients considering the treatments currently available.
- Published
- 2007
34. Pyrosequencing for discovery and analysis of DNA sequence variations.
- Author
-
Ronaghi M, Shokralla S, and Gharizadeh B
- Subjects
- Base Pairing, DNA chemistry, Templates, Genetic, Base Sequence, DNA genetics, Genetic Variation, Polymorphism, Single Nucleotide, Sequence Analysis, DNA methods
- Abstract
Since the invention of pyrosequencing, more than 500 articles have been published describing different applications of this technology, most notably for DNA structure variation and microbial detection. Technological advances have been made to enhance the robustness and accuracy of this technique as well as to reduce the cost and increase the throughput. This review intends to cover recent advances in this technology and discuss its application for low and high-throughput DNA variation studies.
- Published
- 2007
- Full Text
- View/download PDF
35. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance.
- Author
-
Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, and Shafer RW
- Subjects
- DNA, Viral metabolism, Drug Resistance, Viral genetics, Genetic Variation, HIV Protease blood, HIV Reverse Transcriptase blood, HIV-1 enzymology, Humans, Mutation, Anti-HIV Agents therapeutic use, DNA Mutational Analysis methods, HIV Infections drug therapy, HIV Protease genetics, HIV Reverse Transcriptase genetics, HIV-1 genetics
- Abstract
The detection of mutant spectra within a population of microorganisms is critical for the management of drug-resistant infections. We performed ultra-deep pyrosequencing to detect minor sequence variants in HIV-1 protease and reverse transcriptase (RT) genes from clinical plasma samples. We estimated empirical error rates from four HIV-1 plasmid clones and used them to develop a statistical approach to distinguish authentic minor variants from sequencing errors in eight clinical samples. Ultra-deep pyrosequencing detected an average of 58 variants per sample compared with an average of eight variants per sample detected by conventional direct-PCR dideoxynucleotide sequencing. In the clinical sample with the largest number of minor sequence variants, all 60 variants present in > or =3% of genomes and 20 of 35 variants present in <3% of genomes were confirmed by limiting dilution sequencing. With appropriate analysis, ultra-deep pyrosequencing is a promising method for characterizing genetic diversity and detecting minor yet clinically relevant variants in biological samples with complex genetic populations.
- Published
- 2007
- Full Text
- View/download PDF
36. Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain.
- Author
-
Unemo M, Sjöstrand A, Akhras M, Gharizadeh B, Lindbäck E, Pourmand N, Wretlind B, and Fredlund H
- Subjects
- Drug Resistance, Bacterial, Gonorrhea drug therapy, Gonorrhea epidemiology, Humans, Mandatory Reporting, Microbial Sensitivity Tests, Neisseria gonorrhoeae classification, Phylogeny, Sensitivity and Specificity, Sweden epidemiology, Ciprofloxacin pharmacology, Ciprofloxacin therapeutic use, Gonorrhea transmission, Neisseria gonorrhoeae drug effects, Neisseria gonorrhoeae genetics
- Abstract
A highly discriminative and objective genetic characterization of N. gonorrhoeae, which increases our knowledge of strain populations in different geographic areas, is crucial for the development of improved control measures. In the present study, conventional phenotypic characterization and genetic characterization by means of pulsed-field gel electrophoresis (PFGE), sequencing of the entire porB gene, N. gonorrhoeae multiantigen sequence typing (NG-MAST), and pyrosequencing of a quinolone resistance determining region (QRDR) of the gyrA gene of Swedish ciprofloxacin-resistant N. gonorrhoeae serovar IB-10 isolates (n=45) were performed. The genetic characterization identified one widely spread ciprofloxacin-resistant N. gonorrhoeae ST147 strain. In addition, isolates with slightly different genetic characteristics, which presumably reflect the ongoing evolution only, were also identified. All the isolates contained single nucleotide polymorphisms in QRDR of the gyrA gene that are highly correlated with ciprofloxacin resistance. Consequently, comprehensive characterization identified the first confirmed large domestic transmission, mainly among young heterosexuals, of one ciprofloxacin-resistant N. gonorrhoeae strain in Swedish society during 2002-2003. In conclusion, a precise, i.e. genetic, characterization for identification of individual strains is a very valuable support to the crucial active surveillance of the epidemiological characteristics and the antibiotic susceptibility of N. gonorrhoeae in the effective treatment of gonorrhoea.
- Published
- 2007
- Full Text
- View/download PDF
37. A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing.
- Author
-
Parameswaran P, Jalili R, Tao L, Shokralla S, Gharizadeh B, Ronaghi M, and Fire AZ
- Subjects
- DNA Primers chemistry, DNA, Complementary chemistry, Gene Library, Nucleotides analysis, Polymerase Chain Reaction, RNA genetics, Sequence Analysis, DNA methods
- Abstract
Multiplexed high-throughput pyrosequencing is currently limited in complexity (number of samples sequenced in parallel), and in capacity (number of sequences obtained per sample). Physical-space segregation of the sequencing platform into a fixed number of channels allows limited multiplexing, but obscures available sequencing space. To overcome these limitations, we have devised a novel barcoding approach to allow for pooling and sequencing of DNA from independent samples, and to facilitate subsequent segregation of sequencing capacity. Forty-eight forward-reverse barcode pairs are described: each forward and each reverse barcode unique with respect to at least 4 nt positions. With improved read lengths of pyrosequencers, combinations of forward and reverse barcodes may be used to sequence from as many as n(2) independent libraries for each set of 'n' forward and 'n' reverse barcodes, for each defined set of cloning-linkers. In two pilot series of barcoded sequencing using the GS20 Sequencer (454/Roche), we found that over 99.8% of obtained sequences could be assigned to 25 independent, uniquely barcoded libraries based on the presence of either a perfect forward or a perfect reverse barcode. The false-discovery rate, as measured by the percentage of sequences with unexpected perfect pairings of unmatched forward and reverse barcodes, was estimated to be <0.005%.
- Published
- 2007
- Full Text
- View/download PDF
38. Influence of eotaxin 67G>A polymorphism on plasma eotaxin concentrations in myocardial infarction survivors and healthy controls.
- Author
-
Sheikine Y, Olsen B, Gharizadeh B, Jatta K, Tornvall P, and Ghaderi M
- Subjects
- Chemokine CCL11, Chemotactic Factors, Eosinophil, Female, Follow-Up Studies, Gene Frequency, Humans, Male, Middle Aged, Polymerase Chain Reaction, Prognosis, Retrospective Studies, Severity of Illness Index, Survival Rate, Sweden epidemiology, Chemokines, CC blood, Chemokines, CC genetics, DNA genetics, Myocardial Infarction blood, Myocardial Infarction genetics, Myocardial Infarction mortality, Polymorphism, Genetic
- Abstract
Eotaxin (CCL11) is a CC chemokine, whose systemic levels might be associated with coronary artery disease (CAD) and genetic variants predispose to the myocardial infarction (MI). However, the relationship between eotaxin genetic variants and plasma concentrations in CAD patients is still incompletely characterized. We genotyped 311 patients, who survived first MI and 338 controls for a 67G>A single nucleotide polymorphism in the eotaxin gene. By measuring plasma eotaxin concentrations in those subjects we related the former to the presence of 67G>A SNP. There were no differences in eotaxin genotype frequencies between patients and controls. Patient G/G carriers had higher circulating eotaxin levels compared both to G/A and A/A patients (P=0.046) and G/G controls (P=0.028), which might indicate the influence of additional factors (e.g. inflammatory mediators) on eotaxin secretion in those patients. At the same time, eotaxin levels did not differ between patients and controls irrespective of the 67G>A SNP variants they carried. There were no associations between plasma eotaxin levels, biochemical indicators of CAD and the degree of coronary artery stenosis in post-MI patients. Interestingly, some medications taken by the patients (e.g. diuretics and short-acting nitrates) might affect plasma eotaxin levels. In conclusion, our results show that there is no clear association between the presence of eotaxin 67G>A SNP, its plasma levels and CAD parameters in post-MI patients and that circulating eotaxin levels do not differ between subjects with clinical manifestations of coronary atherosclerosis and healthy controls.
- Published
- 2006
- Full Text
- View/download PDF
39. Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis.
- Author
-
Sakthivel P, Wang X, Gharizadeh B, Giscombe R, Pirskanen R, Nyren P, and Lefvert AK
- Subjects
- Alleles, B7 Antigens, Case-Control Studies, Chi-Square Distribution, Electrophoresis, Agar Gel, Ethidium metabolism, Female, Gene Frequency, Humans, Male, Polymerase Chain Reaction, Promoter Regions, Genetic, Antigens, CD genetics, Myasthenia Gravis genetics, Polymorphism, Single Nucleotide genetics, Receptors, Immunologic genetics
- Published
- 2006
- Full Text
- View/download PDF
40. Pyrosequencing of the DNA gyrase gene in Neisseria species: effective indicator of ciprofloxacin resistance in Neisseria gonorrhoeae.
- Author
-
Lindbäck E, Unemo M, Akhras M, Gharizadeh B, Fredlund H, Pourmand N, and Wretlind B
- Subjects
- Amino Acid Sequence, Base Sequence, DNA, Bacterial chemistry, DNA, Bacterial genetics, Drug Resistance, Bacterial, Gram-Negative Bacterial Infections microbiology, Humans, Microbial Sensitivity Tests, Neisseria drug effects, Polymerase Chain Reaction, Sequence Alignment, Anti-Infective Agents pharmacology, Ciprofloxacin pharmacology, DNA Gyrase genetics, Gram-Negative Bacterial Infections drug therapy, Neisseria enzymology, Neisseria genetics
- Abstract
The quinolone resistance determining region (QRDR) of the gyrA gene in ciprofloxacin-susceptible strains (n=53) and strains of Neisseria spp. with reduced susceptibility (n=70) was determined by the pyrosequencing method. Results showed that the QRDR of the gyrA gene is an effective molecular indicator of resistance to ciprofloxacin in Neisseria gonorrhoeae, and presumably in Neisseria meningitidis, but not in all other Neisseria spp. This sequence was not unique for N. gonorrhoeae and seems unsuitable for species verification of N. gonorrhoeae. However, whether it is also possible to use this region for verification depends on the specificity of the primary screening method used.
- Published
- 2006
- Full Text
- View/download PDF
41. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.
- Author
-
Ghaderi M, Gambelunghe G, Tortoioli C, Brozzetti A, Jatta K, Gharizadeh B, De Bellis A, Pecori Giraldi F, Terzolo M, Betterle C, and Falorni A
- Subjects
- Adolescent, Adult, Aged, Child, Female, Genes, MHC Class II, HLA-DQ Antigens genetics, HLA-DQ beta-Chains, HLA-DR Antigens genetics, HLA-DRB1 Chains, Humans, Male, Middle Aged, Nuclear Proteins physiology, Trans-Activators physiology, Adrenal Insufficiency genetics, Autoimmune Diseases genetics, Genetic Predisposition to Disease, Nuclear Proteins genetics, Polymorphism, Single Nucleotide, Trans-Activators genetics
- Abstract
Context: The polymorphism of class II HLA genes modulates the genetic risk for several endocrine autoimmune diseases. The constitutive class II expression on antigen-presenting cells is under the control of the MHC class II transactivator, encoded by the MHC2TA gene, which is mapped to chromosome 16p13. The MHC2TA -168 A-->G single nucleotide polymorphism (rs3087456) has been suggested to confer susceptibility to some autoimmune diseases., Design: With the aim of testing whether this MHC2TA single nucleotide polymorphism is independently associated with autoimmune Addison's disease (AAD) and/or modulates the genetic risk conferred by DRB1-DQA1-DQB1 haplotypes, we analyzed DNA samples from 128 AAD patients and 406 healthy control subjects from continental Italy., Results: Frequency of allele G of MHC2TA was significantly increased among AAD patients (39% alleles), compared with 29% in healthy controls (P = 0.003). Similarly, the frequency of AG+GG genotypes was significantly higher among AAD patients than among healthy control subjects, in both a codominant (P = 0.012) and a G-dominant model (P = 0.018). Multivariate logistic regression analysis showed that MHC2TA AG+GG continued to be positively associated with genetic risk for AAD (P = 0.028, odds ratio = 1.72, 95% confidence interval = 1.06-2.78), after correction for DRB1*03-DQA1*0501-DQB1*0201, DRB1*04 (not 0403)-DQA1*0301-DQB1*0302 and DRB1*0403. Similar results were obtained when the number of G alleles was included in the model (P = 0.004; odds ratio = 1.65, 95% confidence interval = 1.17-2.32)., Conclusions: Our study provides the first demonstration of the association of the polymorphism of the MHC2TA gene with genetic risk for AAD that appears to be independent from the well-known association with the polymorphism of HLA class II genes.
- Published
- 2006
- Full Text
- View/download PDF
42. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
- Author
-
Zheng B, Wiklund F, Gharizadeh B, Sadat M, Gambelunghe G, Hallmans G, Dillner J, Wallin KL, and Ghaderi M
- Subjects
- Base Sequence, Case-Control Studies, DNA Primers, Female, Humans, Logistic Models, Papillomaviridae isolation & purification, Receptors, CCR2, Sweden, Uterine Cervical Neoplasms virology, Polymorphism, Genetic, Receptors, CCR5 genetics, Receptors, Chemokine genetics, Uterine Cervical Neoplasms genetics
- Abstract
Chemokines are chemotactic cytokines that orchestrate leukocyte trafficking in tissues, thus, playing an important role in regulation of immunological processes. The aim of this study was to investigate the association of human papillomavirus (HPV) infection and cervical cancer with two DNA polymorphisms of the chemokine receptors CCR5-delta32 and CCR2-64I. The study material consisted of 50 cervical intraepithelial neoplasia (CIN) cases and 50 of age and sampling-date matched controls, 100 invasive cervix cancer cases and 100 of their corresponding matched disease-free controls. Pyrosequencing was employed to genotype the CCR2-64I polymorphism. CCR5-delta32 was genotyped using standard PCR fragment length analysis. The frequencies of CCR2 and CCR5 genotypes from 150 patients and 150 healthy controls were representative of the general population according to the Hardy-Weinberg equilibrium analysis. Risk association was computed with conditional logistic regression analysis. HPV-positive individuals with the rare CCR5deelta32/delta32 genotype have a risk of 4.58 (CI = 0.40-52.64, p-value = 0.045) compare to HPV negative group. The delta-32 mutation on the CCR locus is imperceptibly associated with increased risk of HPV infection. In total, cervical neoplasia was not associated with genetic polymorphism of CCR2 and CCR5.
- Published
- 2006
43. Large-scale pyrosequencing of synthetic DNA: a comparison with results from Sanger dideoxy sequencing.
- Author
-
Gharizadeh B, Herman ZS, Eason RG, Jejelowo O, and Pourmand N
- Subjects
- Base Sequence, DNA genetics, Sequence Analysis, DNA methods
- Abstract
Pyrosequencing is a relatively recent method for sequencing short stretches of DNA. Because both Pyrosequencing and Sanger dideoxy sequencing were recently used to characterize and validate DNA molecular barcodes in a large yeast gene-deletion project, a meta-analysis of those data allow an excellent and timely opportunity for evaluating Pyrosequencing against the current gold standard, Sanger dideoxy sequencing. Starting with yeast genomic DNA, parallel PCR amplification methods were used to prepared 4747 short barcode-containing constructs from 6000 Saccharomyces cerevisiae gene-deletion strains. Pyrosequencing was optimized for average read lengths of 25-30 bases, which included in each case a 20-mer barcode sequence. Results were compared with sequence data obtained by the standard Sanger dideoxy chain termination method. In most cases, sequences obtained by Pyrosequencing and Sanger dideoxy sequencing were of comparable accuracy, and the overall rate of failure was similar. The DNA in the barcodes is derived from synthetic oligonucleotide sequences that were inserted into yeast-deletion-strain genomic DNA by homologous recombination and represents the most significant amount of DNA from a synthetic source that has been sequenced to date. Although more automation and quality control measures are needed, Pyrosequencing was shown to be a fast and convenient method for determining short stretches of DNA sequence.
- Published
- 2006
- Full Text
- View/download PDF
44. Methodological improvements of pyrosequencing technology.
- Author
-
Gharizadeh B, Akhras M, Nourizad N, Ghaderi M, Yasuda K, Nyrén P, and Pourmand N
- Subjects
- Base Sequence, Molecular Sequence Data, Biotechnology methods, In Situ Hybridization, Fluorescence methods, Luminescent Measurements methods, Sequence Analysis, DNA methods, Specimen Handling methods
- Abstract
Pyrosequencing technology is a rather novel DNA sequencing method based on the sequencing-by-synthesis principle. This bioluminometric, real-time DNA sequencing technique employs a cascade of four enzymatic reactions producing sequence peak signals. The method has been proven highly suitable for single nucleotide polymorphism analysis and sequencing of short stretches of DNA. Although the pyrosequencing procedure is relatively straightforward, users may face challenges due to varying parameters in PCR and sequencing primer design, sample preparation and nucleotide dispensation; such challenges are labor and cost intensive. In this study, these issues have been addressed to increase signal quality and assure sequence accuracy.
- Published
- 2006
- Full Text
- View/download PDF
45. Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomaviruses.
- Author
-
Gharizadeh B, Zheng B, Akhras M, Ghaderi M, Jejelowo O, Strander B, Nyrén P, Wallin KL, and Pourmand N
- Subjects
- DNA Primers biosynthesis, DNA Probes, HPV genetics, DNA, Viral blood, DNA, Viral genetics, Female, Genotype, Humans, Papillomaviridae classification, Papillomaviridae isolation & purification, Papillomavirus Infections blood, Papillomavirus Infections diagnosis, Polymerase Chain Reaction, Risk Factors, Sensitivity and Specificity, Uterine Cervical Dysplasia blood, Uterine Cervical Dysplasia diagnosis, DNA Primers genetics, Papillomaviridae genetics, Papillomavirus Infections virology, Uterine Cervical Dysplasia virology
- Abstract
Despite the various technologies in place for genotyping human papillomaviruses (HPV), clinical use and clinical research demand a method that is fast, more reliable and cost-effective. The technology described here represents a breakthrough development in that direction. By combining the method of multiple sequencing primers with DNA sequencing, we have developed a rapid assay for genotyping HPV that relies on the identification of a single, type-specific 'sentinel' base. As described here, the prototype assay has been developed to recognize the 12 most high-risk HPV types (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59) and is capable of recognizing and simultaneously genotyping multiple HPV co-infections. By providing sequence information on multiple HPV infections, this method eliminates the need for labor- and cost-intensive PCR cloning. These proof-of-concept studies establish the assay to be accurate, reliable, rapid, flexible, and cost-effective, providing evidence of the feasibility this technique for use in clinical settings.
- Published
- 2006
- Full Text
- View/download PDF
46. Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing.
- Author
-
Gharizadeh B, Akhras M, Unemo M, Wretlind B, Nyrén P, and Pourmand N
- Subjects
- Codon, Drug Resistance, Bacterial genetics, Gonorrhea microbiology, Humans, Neisseria gonorrhoeae drug effects, Point Mutation, Species Specificity, Anti-Infective Agents pharmacology, Bacterial Proteins genetics, Ciprofloxacin pharmacology, DNA Gyrase genetics, DNA Mutational Analysis, Neisseria gonorrhoeae genetics
- Abstract
Quinolone resistance is rapidly increasing in Neisseria gonorrhoeae and is posing a significant public health threat that requires constant surveillance. A rapid and reliable mutation detection assay has been developed. The assay is based on pre-programmed short DNA sequencing and is designed to detect point mutations in the gyrA gene that are highly related to ciprofloxacin resistance, i.e. in codons 91 and 95. By developing an assay based on pyrosequencing and exploiting the pre-programmed nucleotide dispensation capability of this technology, the sequence comprising the mutations will be analysed and promptly reveal whether the N. gonorrhoeae pathogen carries resistance to ciprofloxacin. A panel of 40 N. gonorrhoeae clinical isolates, of which 27 phenotypically displayed decreased susceptibility or resistance to ciprofloxacin, was used in the present study. All point mutations in the short stretch of the N. gonorrhoeae gyrA gene were easily discriminated, and the genotypic results obtained by pre-programmed sequencing were mainly in agreement with the phenotypically identified decreased susceptibility or resistance to ciprofloxacin. The new method used in the present study has the potential for rapid and reliable identification of known as well as previously unknown drug resistance mutations.
- Published
- 2005
- Full Text
- View/download PDF
47. Tag-array based HPV genotyping by competitive hybridization and extension.
- Author
-
Käller M, Hultin E, Zheng B, Gharizadeh B, Wallin KL, Lundeberg J, and Ahmadian A
- Subjects
- Alleles, Apyrase, DNA Primers, Female, Humans, Papillomavirus Infections diagnosis, Sensitivity and Specificity, Species Specificity, Templates, Genetic, Gene Expression Profiling methods, Nucleic Acid Hybridization methods, Oligonucleotide Array Sequence Analysis methods, Papillomaviridae genetics, Papillomavirus Infections virology
- Abstract
A method is described for HPV genotyping based on multiplex competitive hybridization (MUCH) combined with apyrase mediated allele-specific extension (AMASE). Two type-specific oligonucleotides were designed for each of the 23 investigated HPV types and directed towards two highly inter-type heterogeneous regions. The type-specific oligonucleotides were allowed to compete in the hybridization to an immobilized template resulting in a highly specific hybridization process. To increase further the specificity, a second step of type discrimination was used in which specific extension of 3'-termini matched oligonucleotides was performed. The 46 type-specific oligonucleotides each had a unique tag sequence to allow detection via an array of oligonucleotides complementary to the tags. To evaluate the genotyping assay, a total of 92 HPV positive samples were tested in this study. Twelve had double infections and five had three to five coexisting HPV types. The results show that MUCH-AMASE can readily detect multiple infections, whereas conventional dideoxy sequencing resulted in ambiguous sequence. Four samples with three to five genotypes detected were cloned and individual clones were sequenced. The cloning procedure verified the MUCH-AMASE results with indications that we can find minor infections (<2% relative amounts). We can thus conclude that the developed assay is highly sensitive, with improved throughput and with excellent possibility to detect multiple infections.
- Published
- 2005
- Full Text
- View/download PDF
48. Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology.
- Author
-
Gharizadeh B, Oggionni M, Zheng B, Akom E, Pourmand N, Ahmadian A, Wallin KL, and Nyrén P
- Subjects
- Female, Genotype, Humans, Male, Papillomaviridae classification, Papillomaviridae isolation & purification, Plasmids genetics, DNA Primers, DNA, Viral analysis, Papillomaviridae genetics, Sequence Analysis, DNA methods
- Abstract
DNA sequencing is the gold standard method for accurate microbial and viral typing. However, DNA sequencing techniques have been facing limitations in typing of human papillomaviruses when the specimen harbors multiple genotypes and yields nonspecific amplification products, resulting in nonspecific and noninterpretable sequence data. To address these limitations we have developed a type-specific multiple sequencing primer DNA-sequencing method. This new strategy is suitable for sequencing and typing of samples harboring different genotypes (co-infections with multiple genotypes) and yielding nonspecific amplifications, thus eliminating the need for nested polymerase chain reaction (PCR), stringent PCR conditions, and cloning. The new approach has also proved useful for amplicons containing low PCR yield or subdominant types, avoiding reperforming of amplifications. We have applied the multiple sequencing primer method for genotyping of clinically relevant human papillomaviruses in a clinical test panel by using a combined pool of seven type-specific sequencing primers for HPV-6, -11, -16, -18, -31, -33, and -45. Furthermore, we introduced a sequence pattern recognition approach when there was a plurality of genotypes in the sample to facilitate typing of more than one target DNA in the sample. The multiple sequencing primer method has proved to be a multifaceted approach for typing of human papillomaviruses by DNA sequencing technologies.
- Published
- 2005
- Full Text
- View/download PDF
49. DNA gyrase gene in Neisseria gonorrhoeae as indicator for resistance to ciprofloxacin and species verification.
- Author
-
Lindbäck E, Gharizadeh B, Ataker F, Airell A, Jalal S, Nyrén P, and Wretlind B
- Subjects
- DNA Topoisomerase IV genetics, Drug Resistance, Bacterial genetics, Sequence Analysis, DNA, Ciprofloxacin pharmacology, DNA Gyrase genetics, Neisseria gonorrhoeae drug effects, Neisseria gonorrhoeae genetics
- Abstract
We have identified a unique region of eight amino acids in the quinolone resistance-determining region in the gyrA gene in Neisseria gonorrhoeae as an indicator of resistance to fluoroquinolones. We sequenced that region by the Pyrosequencing technology in 46 N. gonorrhoeae strains and 11 urine samples positive in AMPLICOR N. gonorrhoeae polymerase chain reaction (Roche Diagnostics), with corresponding isolates of N. gonorrhoeae. The results showed that 28 samples with minimum inhibitory concentration (MIC) of ciprofloxacin >1 mg/L had mutations in positions 91 and 95. Fifteen samples with MIC 0.125-1.0 mg/L had either one or both of the mutations. The 14 susceptible samples had no mutations. The target region also discriminates N. gonorrhoeae from other species of Neisseria. Our conclusion is that gyrA is an indicator of resistance to ciprofloxacin in N. gonorrhoeae and sequencing by Pyrosequencing technology is a suitable tool for analysis of DNA in urine samples.
- Published
- 2005
- Full Text
- View/download PDF
50. Improvements in Pyrosequencing technology by employing Sequenase polymerase.
- Author
-
Gharizadeh B, Eriksson J, Nourizad N, Nordström T, and Nyrén P
- Subjects
- DNA Primers chemistry, Nucleic Acid Conformation, DNA-Directed DNA Polymerase, Diphosphates, Sequence Analysis, DNA methods
- Abstract
Pyrosequencing is a DNA sequencing technique based on the bioluminometric detection of inorganic pyrophosphate, which is released when nucleotides are incorporated into a target DNA. Since the technique is based on an enzymatic cascade, the choice of enzymes is a critical factor for efficient performance of the sequencing reaction. In this study we have analyzed the performance of an alternative DNA polymerase, Sequenase, on the sequencing performance of the Pyrosequencing technology. Compared to the Klenow fragment of DNA polymerase I, Sequenase could read through homopolymeric regions with more than five T bases. In addition, Sequenase reduces remarkably interference from primer-dimers and loop structures that give rise to false sequence signals. By using Sequenase, synchronized extensions and longer reads can be obtained on challenging templates, thereby opening new avenues for applications of Pyrosequencing technology.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.